BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6187653)

  • 1. Keratin proteins and carcinoembryonic antigen in lung carcinoma: an immunoperoxidase study of fifty-four cases, with ultrastructural correlations.
    Said JW; Nash G; Tepper G; Banks-Schlegel S
    Hum Pathol; 1983 Jan; 14(1):70-6. PubMed ID: 6187653
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma.
    Holden J; Churg A
    Am J Surg Pathol; 1984 Apr; 8(4):277-9. PubMed ID: 6201076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3).
    Szpak CA; Johnston WW; Roggli V; Kolbeck J; Lottich SC; Vollmer R; Thor A; Schlom J
    Am J Pathol; 1986 Feb; 122(2):252-60. PubMed ID: 2418688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenocarcinoma of the lung. Immunohistochemical findings (keratin/CEA).
    Brockmann M; Brockmann I; Herberg U; Müller KM
    J Cancer Res Clin Oncol; 1987; 113(4):379-82. PubMed ID: 2439516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of antibodies to carcinoembryonic antigen and human milk fat globule to distinguish carcinoma, mesothelioma, and reactive mesothelium.
    Marshall RJ; Herbert A; Braye SG; Jones DB
    J Clin Pathol; 1984 Nov; 37(11):1215-21. PubMed ID: 6094617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies.
    Ghosh AK; Gatter KC; Dunnill MS; Mason DY
    J Clin Pathol; 1987 Jan; 40(1):19-25. PubMed ID: 2434531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of carcinoembryonic antigen-like material in mesothelioma: an immunohistochemical differentiation from other lung cancers.
    Wang NS; Huang SN; Gold P
    Cancer; 1979 Sep; 44(3):937-43. PubMed ID: 225005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of electron microscopy and immunohistochemistry in the diagnosis and understanding of lung neoplasms.
    Hammar S
    Clin Lab Med; 1987 Mar; 7(1):1-30. PubMed ID: 3030610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical evaluation of pleural mesothelioma and pulmonary adenocarcinoma. A bi-institutional study of 47 cases.
    Otis CN; Carter D; Cole S; Battifora H
    Am J Surg Pathol; 1987 Jun; 11(6):445-56. PubMed ID: 2438954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesothelioma: profile of keratin proteins and carcinoembryonic antigen: an immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas.
    Corson JM; Pinkus GS
    Am J Pathol; 1982 Jul; 108(1):80-8. PubMed ID: 6178295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunodetection of neuron-specific enolase and keratin in cytological preparations as an aid in the differential diagnosis of lung cancer.
    Kyrkou KA; Iatridis SG; Athanassiadou PP; Lambropoulou S; Liossi A
    Diagn Cytopathol; 1986 Sep; 2(3):217-20. PubMed ID: 2429809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoembryonic antigen: immunohistologic identification in invasive and intraepithelial carcinomas of the lung.
    Pascal RR; Mesa-Tejada R; Bennett SJ; Garces A; Fenoglio CM
    Arch Pathol Lab Med; 1977 Nov; 101(11):568-71. PubMed ID: 334106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large cell carcinoma of the lung. Ultrastructural and immunohistochemical features.
    Delmonte VC; Alberti O; Saldiva PH
    Chest; 1986 Oct; 90(4):524-7. PubMed ID: 2428562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of immunoperoxidase staining to the cell blocks from sputa and bronchial washings.
    Lyubsky S; Thorn R
    Arch Pathol Lab Med; 1989 Jan; 113(1):94-5. PubMed ID: 2462860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vimentin, carcinoembryonic antigen and keratin in the diagnosis of mesothelioma, adenocarcinoma and reactive pleural lesions.
    al-Saffar N; Hasleton PS
    Eur Respir J; 1990 Oct; 3(9):997-1001. PubMed ID: 1705232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Histochemical investigation of carcinoembryonic antigen in lung cancer].
    Shirakusa T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Nov; 22(11):1004-11. PubMed ID: 6397653
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytomorphologic findings of malignant mesothelioma in FNA biopsies and touch preps of core biopsies.
    Paintal A; Raparia K; Nayar R
    Diagn Cytopathol; 2016 Jan; 44(1):14-9. PubMed ID: 26303316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localization of prekeratin filaments in benign and malignant cells in effusions. Comparison with intermediate filament distribution by electron microscopy.
    Kahn HJ; Hanna W; Yeger H; Baumal R
    Am J Pathol; 1982 Nov; 109(2):206-14. PubMed ID: 6182803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of tumour markers in malignant mesothelioma and pulmonary adenocarcinoma.
    Gibbs AR; Harach R; Wagner JC; Jasani B
    Thorax; 1985 Feb; 40(2):91-5. PubMed ID: 2579450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12.
    Lee I; Radosevich JA; Chejfec G; Ma YX; Warren WH; Rosen ST; Gould VE
    Am J Pathol; 1986 Jun; 123(3):497-507. PubMed ID: 3717302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.